Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7332 p54
15 January 2005

This article
Reprint   Photocopy

PDF 110K, Acrobat Reader

Letters

· Fellowship of the Society (3)
· Overseas pharmacists (10)
· The Society (5)
· Retention fee (4)
· CPD (4)
· PECs
· Drug donations
· Dispensing errors
· Dispensing
· Morphine sulphate
· Near patient testing
· Slimming clubs
· New contract
· The Journal


Letters to the Editor

Dispensing errors

A question of contributory negligence

From Mr G. Southall-Edwards, MRPharmS

In an item on labels (PJ, 18/25 December 2004, p886), Onlooker states: “Pharmacists are well aware of the need to include all matter of data on a label that will instruct or warn the user of a product, and guide the expert who may be concerned.”

As a pharmacist and lawyer whose firm deals with a great many dispensing errors on behalf of pharmacists’ insurers and as a person who practises pharmacy in mainland European countries where it is not routine practice to label dispensed medicines, I am now wondering whether the continental system of handing out a box in its original state, without a label and perhaps with the patient’s name written on (only rarely, however) is not the better method? I ask this because, just before I read the article, I was dealing with a dispensing error involving the prescription of Voltarol MR 75mg (diclofenac), where Efexor ML 75mg (venlafaxine) was supplied.

Unusually, the pharmacy had supplied a photocopy of the returned container. On the front, it said in large print “Efexor ML 75mg” printed on by the manufacturer. In addition, there was a pharmacy-applied label upon which it said in much smaller print “Voltarol 75mg”. Furthermore, on the end of the box, two other sides and the rear face, the manufacturer had printed “Efexor ML 75mg”; inside the box there was a patient information leaflet for Efexor ML 75mg, in which the treatment of depression was detailed. The manufacturer’s box was also nothing like the colour or design of the Voltarol 75mg pack that the patient was used to.

The letter from the patient to the pharmacist’s insurer states: “I looked at the tablets which were totally different in size, appearance and colour from those I normally get for my arthritis and I noticed that the name had changed too; but on the label it said ‘Voltarol 75mg’ which is what I usually get, plus it had my name on the label, so I took them without further hesitation.” The claimant goes on to say that he read the information leaflet, which described the use of the tablets for depression (and he knew he was not being treated for that), but that he continued to take them, because the “label” said they were Voltarol 75mg. But for the pharmacy label, it seems he would not have taken them, and this is an important factor in as much as 75 per cent of all dispensing errors my firm handles.

The law on “taking the medicine without question” has not yet been tested; I think it is long overdue for testing and hope that it soon will be. Insurers ask (rightly in my opinion) why it is that people who take what is almost obviously wrong should be compensated fully without an allowance being deducted for their contributory negligence, when those who climb into cars and fail to wear their safety belts have, for nearly 30 years, had their damages automatically reduced by at least 15 to 25 per cent.

In the meantime, given that the “correct” labelling of the “wrong” medicine accounts for well-over 60 per cent of all errors I handle, should we not be seriously questioning present practices? Is it now time to reconsider the practice of including the medicine name on the dispensing label? Indeed is it also time to stop putting the patient’s name on the label or box, too, or even stop labelling them altogether and at the same time, by using original packs without exception, come into line with continental Europe? The fact that “it said Mrs Jones on the label” is the other reason, usually given by Mrs Jones, for taking medicines intended for “Mrs Smith”.

My wife has commented many times that it is so much harder to make an error here in Austria, when (in her words) “you do not have to waste all that time printing and applying labels” and the dispensing is done over the pharmacy counter, right in front of the patient, with the prescription and the medicines lying on the counter for both pharmacist and patient to see as the dispensing and patient counselling process proceeds.

G. Southall-Edwards
Tirol, Austria

Send your letter to The Editor

Previous Topic (Drug donations)
Next Topic (Dispensing)

Back to Top


©The Pharmaceutical Journal